Stanford, CA, United States of America

Rachel Lynn

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Rachel Lynn

Introduction

Rachel Lynn is an accomplished inventor based in Stanford, CA (US). She has made significant contributions to the field of immunology, particularly in the development of T cell therapies. With a total of 3 patents to her name, her work focuses on enhancing T cell functionality in therapeutic settings.

Latest Patents

Rachel Lynn's latest patents include groundbreaking inventions aimed at combating T cell exhaustion. One of her notable patents is titled "Compositions and methods for inhibiting T cell exhaustion." This invention relates to T cell compositions and methods of using them in therapy and treatment. It provides modified T cells that maintain functionality under conditions where unmodified T cells exhibit exhaustion. This innovation is crucial for enhancing T cell function against cancer and infectious diseases.

Another significant patent is "Methods of treating T cell exhaustion by inhibiting or modulating T cell receptor signaling." This invention focuses on chimeric antigen receptor (CAR) T cells that are modified to sustain functionality in challenging conditions. The methods disclosed in this patent aim to inhibit or reverse CAR T cell exhaustion, thereby improving their effectiveness in clinical and research settings.

Career Highlights

Rachel Lynn is affiliated with Leland Stanford Junior University, where she conducts her research and development work. Her contributions to the field of immunology have positioned her as a leading figure in T cell therapy innovations.

Collaborations

Rachel collaborates with esteemed colleagues, including Evan Weber and Crystal L Mackall, to further advance her research and innovations in T cell therapies.

Conclusion

Rachel Lynn's work exemplifies the intersection of innovation and medical science, particularly in enhancing T cell functionality for therapeutic applications. Her patents represent significant advancements in the fight against diseases, showcasing her dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…